About Enalapril Maleate API
Therapeutic CategoryCardiovascular
CAS Number
76095-16-4
API Technology
Synthetic
Dose Form
Oral Solids, Liquid
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted, Korea DMF, Russia DMF
Mechanism of Action
Normally, angiotensin I is converted to angiotensin II by an angiotensin-converting enzyme (ACE). Angiotensin II constricts blood vessels, increasing blood pressure. Enalaprilat, the active metabolite of enalapril, inhibits ACE. Inhibition of ACE decreases levels of angiotensin II, leading to less vasoconstriction and decreased blood pressure
Indication
EPANED is an angiotensin-converting enzyme inhibitor indicated for:
- Treatment of hypertension in adults and children older than one month, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal ardiovascular events, primarily strokes and myocardial infarctions.
- Treatment of symptomatic heart failure.
- Treatment of asymptomatic left ventricular dysfunction, to decrease the rate of development of overt heart failure and reduce hospitalization for heart failure.
Related APIs
Metoprolol Succinate
Cardiovascular
Fondaparinux Sodium
Cardiovascular
Clopidogrel Bisulfate (Form 1)
Cardiovascular
Clopidogrel Bisulfate (Form 2)
Cardiovascular
Ramipril
Cardiovascular
Sacubitril-Valsartan
Cardiovascular
Rivaroxaban
Cardiovascular
Valsartan
Cardiovascular
Amlodipine Besylate
Cardiovascular
Apixaban
Cardiovascular
Ticagrelor
Cardiovascular
Treprostinil
Cardiovascular
Lacidipine
Cardiovascular
Atorvastatin Calcium (Amorphous And Form P)
Cardiovascular
Losartan Potassium
Cardiovascular
Ezetimibe
Cardiovascular
Doxazosin Mesylate
Cardiovascular
Bempedoic Acid
Cardiovascular
Dabigatran Etexilate Mesylate
Cardiovascular
Enalapril Maleate
Cardiovascular
Edoxaban
Cardiovascular
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Disclaimer
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.